359 related articles for article (PubMed ID: 12946252)
1. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
[TBL] [Abstract][Full Text] [Related]
2. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in tumor invasion.
Johansson N; Ahonen M; Kähäri VM
Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
[TBL] [Abstract][Full Text] [Related]
4. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and the thyroid.
Kraiem Z; Korem S
Thyroid; 2000 Dec; 10(12):1061-9. PubMed ID: 11201850
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
[TBL] [Abstract][Full Text] [Related]
9. [The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue].
Bogaczewicz J; Jasielski P; Mosiewicz A; Trojanowski T; Suchozebrska-Jesionek D; Stryjecka-Zimmer M
Neurol Neurochir Pol; 2006; 40(5):404-12. PubMed ID: 17103354
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
12. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
13. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Groblewska M; Siewko M; Mroczko B; Szmitkowski M
Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
[TBL] [Abstract][Full Text] [Related]
14. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].
Groblewska M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
17. [Roles of matrix metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) in cancer invasion and metastasis].
Okada A
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2247-52. PubMed ID: 10635313
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells.
Park MJ; Park IC; Hur JH; Rhee CH; Choe TB; Yi DH; Hong SI; Lee SH
Neurosci Lett; 2000 Sep; 290(3):201-4. PubMed ID: 10963898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
